ArticleScientific reports2025
Sex disparity in non-communicable disease burden in Iran from 1990 to 2021 based on the global burden of disease study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- QALY losses for non-communicable diseases in Iranian adults: insights from a national cross-sectional study.Population health metrics · 2026Article
- National and Subnational Burden of Cardiovascular Diseases in Iran from 1990 to 2021: Results from Global Burden of Diseases 2021 study.Global heart · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-communicable diseases (NCDs) pose a major health challenge worldwide, especially in low- and middle-income countries like Iran. Understanding sex disparities in NCDs is crucial for tailoring public health strategies to address unique risks and outcomes for different sexes. This study focused on 11 major NCD categories, estimating incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs). Age-standardized rates were calculated, values were presented with 95% uncertainty intervals (95% UI). Decomposition analysis assessed the impact of population growth, age structure, and incidence rates on incidence and death rates. In 2021, Iran had 80.2 million prevalent NCD cases, with slightly higher age-standardized prevalence in females. The age-standardized incidence rate was higher in females across all age groups, reaching 181,264.4 (95% UI: 165,696.5 to 200,091.3) in females and 131,900.5 (95% UI: 120,657.2 to 145,496.4) in males. Although the age-standardized death rate decreased more in males, it remained higher in males (477.6 (456.7 to 497.2)) than females (438.1 (420.3 to 455.5)). DALYs were moderately higher in females (19,983.4 (16,884.3 to 23,410.1)). In all provinces, YLLs were higher than YLDs for females, while the reverse was true for males in most provinces. These findings underscore the need for targeted public health interventions to address NCDs in females and males. While in males deaths are higher, in females DALYs are slightly higher which calls for tailored intervention to prevent death and disability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.